30 May – 3 June 2025

Meet with Avance Clinical at ASCO 2025 – Your Oncology Clinical Trial Partner

Meet with Avance Clinical at ASCO 2025 – Your Oncology Clinical Trial Partner

Meet with Avance Clinical at ASCO 2025

Visit Us At Booth #36155

Avance Clinical will attend and host a booth at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled from May 30 to June 3, 2025, at McCormick Place in Chicago, Illinois. This premier event brings together oncology professionals from around the world to connect, collaborate, and inspire advancements in cancer care.

Our team of experts will be available to discuss how Avance Clinical can support your oncology clinical trial needs. With over three decades of experience in biotech drug development, we have conducted more than 65 oncology trials in the past five years, demonstrating significant clinical operations expertise in this high-growth sector.

Led by Avance Clinical’s Chief Scientific Officer, Gabriel Kremmidiotis, our team has adopted a solution-oriented, flexible, and agile approach in service delivery, which is particularly applicable and of significance in managing oncology clinical trial. This strategy enables us to adeptly handle the unique demands of clinical trials in cancer research, integrating state-of-the-art technologies and methodologies to enhance trial design and execution while responding with precision to the intricacies of this field.

We specialize in a wide range of oncology indications

Solid Tumors

Sarcomas

  • Ewing’s Sarcoma

Brain Tumors

  • Glioblastoma Multiforme (GBM)

Head and Neck Cancers

Liver Cancers

  • Hepatocellular Carcinoma (HCC)

Skin Cancers

  • Melanoma

Lung Cancers

  • Non-Small Cell Lung Cancer

Other Solid Tumors

  • Renal Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Prostate Cancer

Genetic/Molecular Subtypes (e.g. p53 Mutations)

Hematologic (Blood) Cancers

Leukemias

  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia

Lymphomas

  • B-cell Non-Hodgkin’s Lymphoma
  • Hodgkin’s Lymphoma

Other Hematological Malignancies

  • Multiple Myeloma
  • Myelofibrosis
  • Myeloproliferative Neoplasms

Our comprehensive services are designed to accelerate oncology projects, particularly through the early phases of clinical development ensuring high-quality data and efficient trial execution. Avance Clinical offers its expertise from preclinical through to Late phase studies.

Discover more about key services:

Join us at ASCO 2025 to explore how Avance Clinical’s expertise can advance your oncology drug development journey. We look forward to connecting with you in Chicago.

MEET THE TEAM

Avance Clinical’s expert team will be in attendance

Gabriel Kremmidiotis

Gabriel Kremmidiotis

Chief Scientific Officer

Gabriel Kremmidiotis's LinkedIn Profile

Read more

Liahna Toy

Liahna Toy

Senior Vice President & Head of Early Phase Center of Excellence

Liahna Toy's LinkedIn Profile

Read more

Clint Henry

Clint Henry

Director of Business Development

Clint Henry's LinkedIn Profile

Read more

Dora Vallejo Ardila

Dora Vallejo Ardila

Senior Medical Monitor

Rob Jones

Rob Jones

Director of Strategic Partnerships

Rob Jones's LinkedIn Profile

Read more

Book a meeting

Book a meeting - Generic
Terms and conditions

Related Events